Seok Choi, Jun-Ho Lee, Seikwan Oh, Hyewhon Rhim, Sang-Mok Lee, Seung-Yeol Nah
Index: Mol. Cells 15(1) , 108-13, (2003)
Full Text: HTML
Treatment with ginsenosides, major active ingredients of Panax ginseng, produces a variety of pharmacological or physiological responses with effects on the central and peripheral nervous systems. Recent reports showed that ginsenoside Rg2 inhibits nicotinic acetylcholine receptor-mediated Na+ influx and channel activity. In the present study, we investigated the effect of ginsenoside Rg2 on human 5-hydroxytryptamine3A (5-HT3A) receptor channel activity, which is also one of the ligand-gated ion channel families. The 5-HT3A receptor was expressed in Xenopus oocytes, and the current was measured using the two-electrode voltage clamp technique. The ginsenoside Rg2 itself had no effect on the oocytes that were injected with H2O as well as on the oocytes that were injected with the 5-HT3A receptor cRNA. In the oocytes that were injected with the 5-HT3A receptor cRNA, the pretreatment of ginsenoside Rg2 inhibited the 5-HT-induced inward peak current (I5-HT) The inhibitory effect of ginsenoside Rg2 on I5-HT was dose dependent and reversible. The half-inhibitory concentrations (IC50) of ginsenoside Rg2 was 22.3 +/- 4.6 microM. The inhibition of I5-HT by ginsenoside Rg2 was non-competitive and voltage-independent. These results indicate that ginsenoside Rg2 might regulate the 5-HT3A receptors that are expressed in Xenopus oocytes. Further, this regulation on the ligand-gated ion channel activity by ginsenosides might be one of the pharmacological actions of Panax ginseng.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Ginsenoside Rg2
CAS:52286-74-5 |
C42H72O13 |
Microbial transformation of 20(S)-protopanaxatriol-type sapo...
2007-07-01 [J. Nat. Prod. 70(7) , 1203-6, (2007)] |
Properties of ginseng saponin inhibition of catecholamine se...
1998-01-12 [Eur. J. Pharmacol. 341(2-3) , 139-44, (1998)] |
Characterization of ginseng saponin ginsenoside-Rg(3) inhibi...
2001-10-01 [Biochem. Pharmacol. 62(7) , 943-51, (2001)] |
Enzymatic preparation of ginsenosides Rg2, Rh1, and F1 from ...
2003-03-01 [Planta Med. 69(3) , 285-6, (2003)] |
Enzymatic preparation of ginsenosides Rg2, Rh1, and F1.
2003-04-01 [Chem. Pharm. Bull. 51(4) , 404-8, (2003)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved